
Capital Markets
Corporate Governance
Retail & Consumer Products
Healthcare
Technology
Michael Benjamin is a Partner at Latham & Watkins, based in New York City. As the Global Chair of the Retail & Consumer Products Industry Group, he represents issuers and investment banks in a wide array of public and private transactions. Michael has developed a leading capital markets practice, focusing on initial public offerings, follow-on offerings, and various debt offerings. He also advises on corporate governance and general corporate matters across industries such as consumer retail products, healthcare, and technology. With extensive experience in capital markets, Michael is a trusted advisor to both U.S. and international corporations.
- K2 Medical Research acquired K2 Medical Research from K2 Medical Research in a private equity on 2024-06-20. - Deal value was 500000000 (source: AI Estimation) Ownership: significant strategic growth investment; Sector: Healthcare; Location: USA. - On the acquirer side, Latham & Watkins advised, led by John Miller, Justin Hamill, Michael Benjamin.
Jun 20 2024
500M
Private Equity
Partner
2016 – Unknown
Associate Attorney
2016 – 2016
Law Clerk
2015 – 2016
- Organon acted as the acquirer in this Financing transaction. - The acquisition targeted assets operating in the Healthcare sector. - The transaction was announced on 17 May 2024 with a reported value of 10000000000.0.
May 17 2024
1B
Finance
1 min
Legal Clerk
2015 – 2015
Student Clinician
2014 – 2014
Judicial Extern to the Honorable Timothy McCormack
2014 – 2014
Law Clerk
2013 – 2014
Events and Outreach Coordinator
2010 – 2012